Cursos

← vista completa

Publicado el 1 de mayo de 2005 | http://doi.org/10.5867/medwave.2005.04.3588

Metástasis óseas del cáncer de mama

Bone metastases from breast cancer

Alejandro Acevedo G.

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Alejandro Acevedo G.

Oncólogo, Centro Médico Clínica Reñaca, Viña del Mar, Chile

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Acevedo G. A. Bone metastases from breast cancer. Medwave 2005;5(04):e3588 doi: 10.5867/medwave.2005.04.3588

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 01/05/2005

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Referencias

  1. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987 Jan;55(1):61-6. | CrossRef | PubMed
  2. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001 Jun;27(3):165-76. | CrossRef | PubMed
  3. Roodman GD. Mechanisms of Bone Metastasis. N Engl J Med. 2004 Apr 15;350(16):1655-64. | CrossRef | PubMed
  4. Paget S. The distribution of secondary growths of breast cancer. Lancet 1889; 1:571-3. | Link
  5. Liotta LA, Kohn E. Cancer invasion and metastases. JAMA. 1990 Feb 23;263(8):1123-6. | CrossRef | PubMed
  6. Rodan GA. The Development and Functions of Skeleton and Bone Metastasis. Cancer. 2003 Feb 1;97(3 Suppl):726-32. | CrossRef | PubMed
  7. Diel SJ. Biphosphonates in the prevention of bone metastases: current evidence. Semin Oncol. 2001 Aug;28(4 Suppl 11):75-80. | CrossRef | PubMed
  8. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A. 1987 Jul;84(14):5048-52. | CrossRef | PubMed
  9. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res. 1991 Jun 1;51(11):3059-61. | PubMed
  10. Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, et al Inmunohistochemical localization of parathyroid hormone-related protein in breast cancer. Cancer Res. 1990 Dec 1;50(23):7710-6. | PubMed
  11. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, et al. Evidence of causal rol of parathyroid hormone-related protein in breast cancer mediated osteolysis. J Clin Invest. 1996 Oct 1;98(7):1544-9. | CrossRef | PubMed
  12. Miki T, Yano S, Hanibuchi M, Sone S. Bone metastasis model with multiorgan dissemination of human small-cell (SBC 5) cancer in natural killer cell-depleted SCID mice. Oncol Res. 2000;12(5):209-17. | PubMed
  13. Pfeilschifter J, Mundy GR. Modulation of transforming growth factor beta activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci U S A. 1987 Apr;84(7):2024-8. | CrossRef | PubMed
  14. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, et al. TGF-Beta signaling blockade inhibits PTHrP secretion by breast cancer cell and bone metastases development. J Clin Invest. 1999 Jan;103(2):197-206. | CrossRef | PubMed
  15. Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, et al. TGF-Beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem. 2002 Jul 5;277(27):24571-8. Epub 2002 Apr 18. | CrossRef | PubMed
  16. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ, et al. Breast cancer cell interact with osteoblast to support osteoclast formation. Endocrinology. 1999 Oct;140(10):4451-8. | CrossRef | PubMed
  17. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11924-8. | CrossRef | PubMed
  18. Hughes FJ, Howells GL. et al. Interleikin-11 inhibits bone formation in vitro. Calcif Tissue Int. 1993 Nov;53(5):362-4. | CrossRef | PubMed
  19. Lacroix M, Siwek B, Marie PJ, Body JJ. Production and regulation of interleukin-11 by breast cancefr cells. Cancer Lett. 1998 May 15;127(1-2):29-35. | CrossRef | PubMed
  20. Yoneda T, Sasaki A, Dunstan C, Williams PJ, Bauss F, De Clerck YA, et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest. 1997 May 15;99(10):2509-17. | CrossRef | PubMed
  21. Zakalik D, Diep D, Hooks MA, Nissenson RA, Strewler GJ. Transforming growth factor beta increases stability of parathyroid hormone related protein messenger RNA. J Bone Miner Res. 1992;7(Suppl 1):104.
  22. Merryman JI, DeWille JW, Werkmeister JR, Capen CC, Rosol TJ. Effects of transforming growth factor beta on parathyroid hormone-related protein production and ribonucleic acid expression by a squamou carcinoma cell in vitro. Endocrinology. 1994 Jun;134(6):2424-30. | CrossRef | PubMed
  23. Yi B, Williams PJ, Niewolna M, Wang Y, Yoneda T. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteoesclerotic bone metastases in an animal model of himan breast cancer. Cancer Res. 2002 Feb 1;62(3):917-23. | PubMed
  24. Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. Differential expression of insuline-like growth factor-I and II messenger ribonucleic acid in growing rat bone. Endocrinology. 1993 Mar;132(3):1158-67. | CrossRef | PubMed
  25. Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. J Surg Res. 2001 Sep;100(1):18-24. | CrossRef | PubMed
  26. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al. Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites. Cancer Res. 1991 Jun 1;51(11):3059-61. | PubMed
  27. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul MC, Jullienne A. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res. 1993 Nov 1;53(21):5076-8. | PubMed
  28. Sugimoto T, Shiba E, Watanabe T, Takai S. Suppression of parathyroid hormone-related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues. Breast Cancer Res Treat. 1999 Jul;56(1):11-23. | CrossRef | PubMed
  29. Colleoni M, O'Neill A, Goldhirsch A, Gelber RD, Bonetti M, Thürlimann B, et al. Identifying Breast cancer Patients at High risk for Bone Metastases. J Clin Oncol. 2000 Dec 1;18(23):3925-35. | PubMed
  30. Henderson M, Danks J, Moseley J, Slavin J, Harris T, McKinlay M, et al. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst. 2001 Feb 7;93(3):234-7. | CrossRef | PubMed
  31. Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, et al. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cell correlates with bone metastasis in vivo. Cancer Res. 2002 Oct 1;62(19):5571-9. | PubMed